Design: A randomized clinical trial, phase 3 study of the population of 29 individuals, including 14 in the control group and 15 patients without blinding
How to study and interventions and participants: All patients regularly undergo periodic tests, renal, hematologic and biochemical and standard treatment, normal, and defined these diseases include supportive therapy and blood product administration, as required by If symptoms are severe or clinical laboratory and blood coagulation (DIC) immediately admitted in ICU hospital patients in the study group after the initial application by the blood, are treated with plasmapheresis. (in plasmapheresisa pilot study carried out for each patient is considered average 3 times).
The main outcome: platelet count; ceratinin
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2015110524884N1
Registration date:2016-06-29, 1395/04/09
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2016-06-29, 1395/04/09
Registrant information
Name
Mitra Moghaddaspour
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 21 2243 9937
Email address
moghaddaspour@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Investigator
Expected recruitment start date
2015-11-22, 1394/09/01
Expected recruitment end date
2016-11-21, 1395/09/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of efficacy of Plasmaphresis in Disseminated Intravascular Coagulation after a sting of Hemiscorpius lepturus
Public title
Evaluation of efficacy of Plasmaphresis in Disseminated Intravascular Coagulation after a sting of Hemiscorpius lepturus
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: Laboratory and clinical signs of disseminated intravascular coagulation (DIC) for scorpion stung
Exclusion criteria: death
Age
No age limit
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
29
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Shahid Beheshti University of Medical Sciences